For patients with cardiovascular disease but not chronic kidney disease, SGLT-2 inhibitors reduce overall mortality with an NNT of 39 (95% CI, 27 to 72) over five years
This powerful peptide combination offers synergistic effects that go beyond what either compound can achieve alone, making proper dosing protocols essential for anyone considering this therapy
Free from GMOs, artificial colours, and unnecessary additives, ensuring a clean and reliable supplement experience
Yes, youve already been on a GLP-1 medication, but tirzepatide works on two receptors instead of one, so your body needs time to get used to it
Schedule Your Free Consultation Disclaimer: This article is for informational purposes only and doesn't constitute medical advice
10.1210/jcem.85.12.7043 J